The 2024 #RAREis Global Advocate Grant recipients have been announced. Learn more about the 75 awardees, here.
More information will be available in early 2025.
Select Your Language:
Congratulations To This Year's Recipients
As part of our mission, we strive to improve the experience of living with a rare disease by providing support to many organizations that offer crucial programs and services for people living with rare diseases.
The #RAREis Global Advocate Grant was established in 2022 to support the rare disease community by providing financial assistance to global advocacy groups working to advance, educate and address the needs of the community.
In 2024, we committed to provide 75 one-time $5,000 grants to global rare disease advocacy organizations to support programs and disease education initiatives. Please complete the application below to submit your organization for a #RAREis Global Advocate Grant by 5 p.m. CT on May 31, 2024. Recipients will be announced in August.
To qualify for consideration, an organization must be considered a non-profit organization, focused on supporting the rare disease community outside of Amgen’s disease states, all funds will be used in the year received and no healthcare providers will be receiving benefit from this grant. Past grant awardees are eligible to reapply and receive repeat funding.
#RAREis engaged Global Advocate Grant awardees representing 14 countries through a survey and live summit to discern the biggest challenges advocacy groups from around the world face and areas for opportunity.
Read the findings that uncover valuable insights around barriers affecting access to care, funding obstacles, mental health challenges, the hurdles impeding diversity, equity and inclusion and opportunities for collaboration in the rare disease community.